Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
Authors
Julie Irving,
Elizabeth MathesonLynne Minto,
Helen Blair,
Marian Case,
Christina Halsey,
Isabella Swidenbank,
Frida Ponthan,
Renate Kirschner‐Schwabe,
Stefanie Groeneveld‐Krentz,
Jana Hof,
James Allan,
Christine Harrison,
Josef Vormoor,
Arend Stackelberg +13 authors
,
Cornelia Eckert Tip Tip